GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Globus Medical Inc (MEX:GMED) » Definitions » Net Change in Cash

Globus Medical (MEX:GMED) Net Change in Cash : MXN1,872 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Globus Medical Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Globus Medical's Net Change in Cash for the three months ended in Jun. 2024 was MXN1,033 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was MXN1,872 Mil.

Globus Medical Net Change in Cash Historical Data

The historical data trend for Globus Medical's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Globus Medical Net Change in Cash Chart

Globus Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,055.73 868.74 -950.37 -830.59 5,377.88

Globus Medical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,521.81 -467.38 3,185.59 -1,879.19 1,032.56

Globus Medical Net Change in Cash Calculation

Globus Medical's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=4133.212+5142.654+-3934.987+37.004
=5,378

Globus Medical's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=994.012+-190.126+159.55+69.122
=1,033

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,872 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Globus Medical's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Globus Medical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Globus Medical Inc (MEX:GMED) » Definitions » Net Change in Cash
Comparable Companies
PEN SWAV BIO BRKR INSP MASI QDEL PODD NARI GKOS ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
GMED:USA GM0N:Germany
Address
2560 General Armistead Avenue, Audubon, PA, USA, 19403
Website
https://www.globusmedical.com
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.